Form 4: Jupiter Neurosciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Holger Weis, a Director of Jupiter Neurosciences, Inc., reported multiple transactions in common stock on June 2, 2025.
Summary
- Option exercise/conversion: acquired 85,800 Common Stock on June 2, 2025; holds 96,581 after (Direct).
- Option exercise/conversion: disposed of 85,800 Restricted Stock Units on June 2, 2025 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Holger Weis — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2025-06-02 | Option exercise/conversion | Common Stock | 85,800 | — | — | 96,581 |
| 2025-06-02 | Option exercise/conversion | Restricted Stock Units | 85,800 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2025-06-02 | Option exercise/conversion (85,800 shares) |
| 2025-06-02 | Option exercise/conversion (85,800 shares) |
Keywords
insider transaction, Form 4, JUNS, JUPITER NEUROSCIENCES, INC., neutral, Holger Weis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.